Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

被引:0
|
作者
Se Hoon Park
Yuna Lee
Sang Hoon Han
So Young Kwon
Oh Sang Kwon
Sun Suk Kim
Ju Hyun Kim
Yeon Ho Park
Jeong Nam Lee
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
机构
[1] Department of Medicine,Division of Hematology and Oncology
[2] Gachon Medical School Gil Medical Center,Division of Gastroenterology
[3] Department of Medicine,Department of General Surgery
[4] Gachon Medical School Gil Medical Center,undefined
[5] Gachon Medical School Gil Medical Center,undefined
来源
BMC Cancer | / 6卷
关键词
Doxorubicin; Capecitabine; Bortezomib; Gastric Variceal Bleeding; Triplet Combination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma
    Lee, J. O.
    Lee, K. W.
    Oh, D. Y.
    Kim, J. H.
    Im, S. A.
    Kim, T. Y.
    Bang, Y. J.
    ANNALS OF ONCOLOGY, 2009, 20 (08) : 1402 - 1407
  • [2] Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
    Shim, Ju Hyun
    Park, Joong-Won
    Nam, Byung Ho
    Lee, Woo Jin
    Kim, Chang-Min
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 459 - 467
  • [3] Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
    Lee, J
    Park, JO
    Kim, WS
    Park, SH
    Park, KW
    Choi, MS
    Lee, JH
    Koh, KC
    Paik, SW
    Yoo, BC
    Joh, J
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (05) : 385 - 390
  • [4] Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma
    Jeeyun Lee
    Joon Oh Park
    Won Seog Kim
    Se Hoon Park
    Keon Woo Park
    Moon Seok Choi
    Joon Hyoek Lee
    Kwang Cheol Koh
    Seung Woon Paik
    Byung Chul Yoo
    Jaewon Joh
    Kihyun Kim
    Chul Won Jung
    Young Suk Park
    Young-Hyuck Im
    Won Ki Kang
    Mark H. Lee
    Keunchil Park
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 385 - 390
  • [5] Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma
    Ju Hyun Shim
    Joong-Won Park
    Byung Ho Nam
    Woo Jin Lee
    Chang-Min Kim
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 459 - 467
  • [6] Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
    Jeng-Nian Yuan
    Yee Chao
    Wei-Ping Lee
    Chung-Pin Li
    Rheun-Chuan Lee
    Full-Young Chang
    Sang-Hue Yen
    Shou-Dong Lee
    Jacqueline Whang-Peng
    Medical Oncology, 2008, 25 : 201 - 206
  • [7] Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
    Yuan, Jeng-Nian
    Chao, Yee
    Lee, Wei-Ping
    Li, Chung-Pin
    Lee, Rheun-Chuan
    Chang, Full-Young
    Yen, Sang-Hue
    Lee, Shou-Dong
    Whang-Peng, Jacqueline
    MEDICAL ONCOLOGY, 2008, 25 (02) : 201 - 206
  • [8] Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinoma
    Schmid, Irene
    Haeberle, Beate
    Albert, Michael H.
    Corbacioglu, Selim
    Froehlich, Birgit
    Graf, Norbert
    Kammer, Birgit
    Kontny, Udo
    Leuschner, Ivo
    Scheel-Walter, Hans-Gerhard
    Scheurlen, Wolfram
    Werner, Sebastian
    Wiesel, Thomas
    von Schweinitz, Dietrich
    PEDIATRIC BLOOD & CANCER, 2012, 58 (04) : 539 - 544
  • [9] Beyond chemotherapy: systemic treatment options for hepatocellular carcinoma
    Topp, Zheng Z.
    Sigal, Darren S.
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (06) : 482 - 491
  • [10] Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
    Lacin, Sahin
    Esin, Ece
    Karakas, Yusuf
    Yalcin, Suayib
    ONCOTARGETS AND THERAPY, 2015, 8 : 1039 - 1042